JACC Author Interviews

American College of Cardiology
  • ٠٫٠ (٠)
  • طب
  • يتم التحديث يوميًا

Interviews with top cardiologists and cardiovascular researchers about breakthrough research, clinical trials, and emerging innovations featured in JACC.

  1. قبل ٦ أيام

    Behind The Science: Radiomic Profiling of Epicardial Fat for Heart Failure Prediction | JACC

    In this episode of Behind the Science, host Adith Arun sits down with Dr. Evangelos Oikonomou to discuss groundbreaking research published in JACC: "Early Prediction of Heart Failure from Routine Cardiac CT Using Radiomic Phenotyping of Epicardial Fat." Dr. Oikonomou walks us through how AI-powered radiomic analysis of epicardial adipose tissue, the fat layer directly surrounding the heart, can serve as an early biomarker for heart failure risk, even in patients with no prior diagnosis. The study draws on over 60,000 coronary CT angiography cases from nine UK sites (the ORFNI consortium) to build and validate a fully automated risk scoring model. Topics covered: Why BMI falls short as a cardiovascular risk measure What epicardial fat reveals about myocardial disease How radiomics extracts hidden phenotypic features from CT images Model training, validation, and multi-site generalizability How the FRP (Fat Radiomic Profile) score is orthogonal to existing tools like PREVENT Implications for GLP-1 therapies and obesity-directed treatment eligibility The future of longitudinal monitoring and prospective enrichment studies This research represents a major step toward extracting untapped prognostic value from CT scans already being performed in clinical practice.

    ٢٦ د

  2. ٢٣ يونيو

    Behind the Science: Using Coronary Calcium to Improve Lipoprotein(a) Risk Prediction | JACC Author Interviews

    In this episode of Behind the Science, we explore how coronary artery calcium scoring improves cardiovascular risk assessment in patients with elevated lipoprotein(a). This multicohort study highlights how Lp(a) and CAC serve as independent predictors of ASCVD and how combining both tools enhances risk stratification in clinical practice. Learn how calcium scoring can help identify higher risk individuals, guide preventive cardiology decisions, and support personalized treatment strategies. This discussion is essential for clinicians focused on heart disease prevention, lipid disorders, and advanced cardiovascular imaging.

    ١٤ د

  3. ١٩ يونيو

    Behind the Science: Excess Cardiovascular Mortality Among Black Americans | JACC

    Listen in to JACC's perspective on our newest research, published on June 19 and featuring co-authors Adith Arun, BS, Clyde W. Yancy, MD, MSc. We present readers with another update in our Data Report Series, evaluating trends in excess cardiovascular mortality among Black Americans compared with White Americans from 2000 to 2024 and persistent disparities in outcomes. While modest improvements were observed in 2024 after pandemic-related increases, progress remains uneven, with heart failure mortality continuing to rise—especially among women. The overall burden remains high, with more than one million excess years of potential life lost annually and hypertension as the leading contributor. Long-term patterns show that earlier gains in reducing disparities have stalled, with current gaps resembling those seen in the mid-2010s. The findings emphasize that advances in cardiovascular care have not translated into equitable outcomes and call for sustained structural and policy interventions. #jacc #jaccjournals #jaccdatareport

    ١٨ د

  4. ٢ يونيو

    DCB vs DES in Noncomplex Coronary Bifurcation Lesions: REC CAGEFREE I | JACC: Cardiovascular Interventions

    Dr. Aaysha Cader, Social Media editor for JACC Interventions and Dr. Chao Gao discuss the pre-specified subgroup analysis of the REC-CAGEFREE I trial: Drug-Coated Balloon Angioplasty vs Drug-Eluting Stents in Noncomplex Coronary Bifurcation Lesions.

    ١٣ د

  5. ٢ يونيو

    Side Branch Treatment for Bifurcation Revascularization: KISS Trial | JACC: Cardiovascular Interventions

    Dr. Aaysha Cader, Social Media editor for JACC Interventions and Dr. Antoinette Neylon discuss the randomised KISS trial: Side Branch Additional Treatment for Coronary Bifurcation Lesion Revascularization.

    ١٤ د

  6. ١٩ مايو

    Behind the Science: NPR-1 Agonist for Resistant Hypertension | JACC Author Interviews

    Join us for the latest Behind the Science discussion, featuring an article published in JACC's May 12 focus issue on hypertension. Adith Arun, MD, joins author William B. White, MD, as they discuss a phase 2 randomized trial of the NPR1 agonist XXB750 in patients with resistant hypertension. The interview highlights the study, a randomized, double-blind, placebo-controlled trial of 4 doses of XXB750, administered once-monthly by subcutaneous injection in 189 patients with resistant hypertension. Dose-related changes in cyclic GMP were observed, supporting target engagement of XXB750 at the NPR-1 receptor. However, there was no dose-response pattern observed with respect to change from baseline in 24-hour systolic BP after 12 weeks; none of the doses of XXB750 had a greater BP lowering effect than placebo. #jacc #jaccjournals #behindthescience

    ٢٨ د

  7. ١٢ مايو

    Global Hypertension 2000 to 2020 | JACC Author Interviews

    In this interview in JACC's May 12 issue focusing on hypertension, JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, MACC speaks with first author Samantha S. O'Connell, MS, MD, as they discuss a comprehensive global analysis of hypertension trends from 2000 to 2020, drawing on data from nearly 300 population-based studies across 119 countries. The findings show that while awareness and treatment have improved modestly—especially in high-income countries—the global burden of hypertension has grown to 1.7 billion adults, with most uncontrolled cases now concentrated in low- and middle-income countries. The conversation emphasizes widening disparities, persistently low control rates, and the urgent need to implement proven strategies worldwide.

    ٢٦ د

  8. ٢١ أبريل

    Behind the Science: AI in Cardiovascular Clinical Trials | JACC

    Can artificial intelligence really adjudicate heart attacks, strokes, and cardiovascular deaths in clinical trials? Adith Arun sits down with Jonathan W. Cunningham to discuss cutting-edge research using AI to automate major adverse cardiovascular event (MACE) adjudication—one of the most expensive and time‑consuming parts of global clinical trials. They explore how AI models review extensive medical records, assess uncertainty, and work alongside physicians in a hybrid approach that can preserve accuracy while improving efficiency and scalability in large trials.

    ١٦ د
مشاهدة الكل (٤٩)

حول

Interviews with top cardiologists and cardiovascular researchers about breakthrough research, clinical trials, and emerging innovations featured in JACC.

المعلومات

  • صناع العمل
    American College of Cardiology
  • سنوات النشاط
    ٢٠٢٦
  • الحلقات
    ٤٩
  • التقييم
    ملائم
  • حقوق النشر
    © American College of Cardiology Foundation. All rights reserved.
  • موقع البرنامج على الويب
    JACC Author Interviews

قد يعجبك أيضًا